Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur

Background. Most orthopaedic units do not have a policy for reversal of anticoagulation in patients with hip fractures. The aim of this study was to examine the current practice in a district general hospital and determine difference in the time to surgery, if any, with cessation of warfarin versus...

Full description

Bibliographic Details
Main Authors: Ashouri, Feras, Al-Jundi, Wissam, Patel, Akash, Mangwani, Jitendra
Format: Online
Language:English
Published: International Scholarly Research Network 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195383/
id pubmed-3195383
recordtype oai_dc
spelling pubmed-31953832011-11-14 Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur Ashouri, Feras Al-Jundi, Wissam Patel, Akash Mangwani, Jitendra Clinical Study Background. Most orthopaedic units do not have a policy for reversal of anticoagulation in patients with hip fractures. The aim of this study was to examine the current practice in a district general hospital and determine difference in the time to surgery, if any, with cessation of warfarin versus cessation and treatment with vitamin K. Methods. A retrospective review of the case notes between January 2005 and December 2008 identified 1797 patients with fracture neck of femur. Fifty seven (3.2%) patients were on warfarin at the time of admission. Patients were divided into 2 groups (A and B). Group A patients (16/57; 28%) were treated with cessation of warfarin only and group B patients (41; 72%) received pharmacological therapy in addition to stopping warfarin. Time to surgery between the two groups was compared. Results. The mean INR on admission was 2.9 (range 1.7–6.5) and prior to surgery 1.4 (range 1.0–2.1). Thirty eight patients received vitamin K only and 3 patients received fresh frozen plasma and vitamin K. The average time to surgery was 4.4 days in group A and 2.4 days in group B. The difference was statistically significant (P < .01). Conclusion. Reversal of high INR is important to avoid significant delay in surgery. There is a need for a national policy for reversing warfarin anticoagulation in patients with hip fractures requiring surgery. Vitamin K is safe and effective for anticoagulation reversal in hip fracture patients. International Scholarly Research Network 2011 2011-02-24 /pmc/articles/PMC3195383/ /pubmed/22084696 http://dx.doi.org/10.5402/2011/294628 Text en Copyright © 2011 Feras Ashouri et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ashouri, Feras
Al-Jundi, Wissam
Patel, Akash
Mangwani, Jitendra
spellingShingle Ashouri, Feras
Al-Jundi, Wissam
Patel, Akash
Mangwani, Jitendra
Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
author_facet Ashouri, Feras
Al-Jundi, Wissam
Patel, Akash
Mangwani, Jitendra
author_sort Ashouri, Feras
title Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
title_short Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
title_full Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
title_fullStr Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
title_full_unstemmed Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur
title_sort management of warfarin anticoagulation in patients with fractured neck of femur
description Background. Most orthopaedic units do not have a policy for reversal of anticoagulation in patients with hip fractures. The aim of this study was to examine the current practice in a district general hospital and determine difference in the time to surgery, if any, with cessation of warfarin versus cessation and treatment with vitamin K. Methods. A retrospective review of the case notes between January 2005 and December 2008 identified 1797 patients with fracture neck of femur. Fifty seven (3.2%) patients were on warfarin at the time of admission. Patients were divided into 2 groups (A and B). Group A patients (16/57; 28%) were treated with cessation of warfarin only and group B patients (41; 72%) received pharmacological therapy in addition to stopping warfarin. Time to surgery between the two groups was compared. Results. The mean INR on admission was 2.9 (range 1.7–6.5) and prior to surgery 1.4 (range 1.0–2.1). Thirty eight patients received vitamin K only and 3 patients received fresh frozen plasma and vitamin K. The average time to surgery was 4.4 days in group A and 2.4 days in group B. The difference was statistically significant (P < .01). Conclusion. Reversal of high INR is important to avoid significant delay in surgery. There is a need for a national policy for reversing warfarin anticoagulation in patients with hip fractures requiring surgery. Vitamin K is safe and effective for anticoagulation reversal in hip fracture patients.
publisher International Scholarly Research Network
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3195383/
_version_ 1611481667079241728